| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
22,716 |
21,535 |
$2.18M |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
16,770 |
5,716 |
$444K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
7,221 |
7,037 |
$293K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,047 |
2,968 |
$239K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
16,383 |
15,889 |
$235K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,224 |
6,043 |
$174K |
| 99233 |
Prolong inpt eval add15 m |
4,490 |
1,374 |
$129K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
230 |
230 |
$32K |
| 99223 |
Prolong inpt eval add15 m |
352 |
346 |
$22K |
| 99215 |
Prolong outpt/office vis |
92 |
91 |
$14K |
| 87807 |
|
967 |
931 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
218 |
212 |
$6K |
| 87428 |
|
187 |
186 |
$5K |
| 99222 |
Initial hospital care, per day, moderate complexity |
69 |
69 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
33 |
33 |
$3K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
50 |
50 |
$546.83 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
16 |
16 |
$340.92 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
65 |
65 |
$7.77 |